Circulating let-7f-5p improve risk prediction of prostate cancer in patients with benign prostatic hyperplasia

Background: Although the prostate-specific antigen (PSA) testing was widely used for early detection of prostate cancer (PCa), it is difficult for PSA to distinguish the PCa from benign prostatic hyperplasia (BPH) patients. Emerging evidence has shown that microRNA (miRNA) was a promising biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Yuqiu, Wang, Qiangdong, Shao, Wei, Zhao, You, Shi, Qianqian, Yuan, Qinbo, Cui, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255360/
https://www.ncbi.nlm.nih.gov/pubmed/32489471
http://dx.doi.org/10.7150/jca.45077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255360/
https://www.ncbi.nlm.nih.gov/pubmed/32489471
http://dx.doi.org/10.7150/jca.45077

Ejemplares similares